Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AMERICAN INTERNATIONAL GROUP, INC. | EVP and CIO | Common Stock | 63.4K | $4.28M | $67.50 | Jun 2, 2021 | Direct |
PNC FINANCIAL SERVICES GROUP, INC. | Director | $5 Par Common Stock | 100 | $19.8K | $198.13 | Feb 3, 2025 | Direct |
PNC FINANCIAL SERVICES GROUP, INC. | Director | Phantom Stock Unit | 55 | $9.61K | $174.64 | Apr 1, 2025 | Deferred Compensation Plan |
AMERICAN INTERNATIONAL GROUP, INC. | EVP and CIO | 2020 Restricted Stock Units | 29.7K | Jun 29, 2021 | Direct | ||
AMERICAN INTERNATIONAL GROUP, INC. | EVP and CIO | 2019 Restricted Stock Units | 28.7K | Jun 29, 2021 | Direct | ||
BridgeBio Pharma, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 21, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PNC | PNC FINANCIAL SERVICES GROUP, INC. | Apr 1, 2025 | 1 | $9.61K | 4 | Apr 3, 2025 | Director |
PNC | PNC FINANCIAL SERVICES GROUP, INC. | Feb 3, 2025 | 1 | $19.8K | 4 | Feb 5, 2025 | Director |
PNC | PNC FINANCIAL SERVICES GROUP, INC. | Feb 3, 2025 | 0 | $0 | 3 | Feb 4, 2025 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2024 | 1 | $0 | 4 | Jun 25, 2024 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 21, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
BBIO | BridgeBio Pharma, Inc. | Jun 22, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Mar 14, 2022 | 1 | $81.9K | 4 | Mar 16, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Jan 4, 2022 | 2 | $164K | 4 | Jan 6, 2022 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 17, 2021 | 1 | $0 | 4 | Aug 26, 2021 | Director |
BBIO | BridgeBio Pharma, Inc. | Aug 17, 2021 | 0 | $0 | 3 | Aug 26, 2021 | Director |
AIG | AMERICAN INTERNATIONAL GROUP, INC. | Jun 29, 2021 | 2 | $0 | 4 | Jul 1, 2021 | EVP and CIO |
AIG | AMERICAN INTERNATIONAL GROUP, INC. | Jun 2, 2021 | 2 | -$1.05M | 4 | Jun 4, 2021 | EVP and CIO |